CAR NKT Cell Therapy Shows Promise Against Neuroblastoma in Phase 1 Trial
Baylor College of Medicine
Trial validates localization of NKT cells to tumor sites in humans and points to high in vivo antitumor activity
AACC recommends supporting data harmonization and incentivizing stakeholders who meet the clinical data sharing requirements
Educating patients about clinical trials they can participate in is an innovative way to improve inclusivity